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Resumo
A avaliação de lesões anexiais indeterminadas 
em ecografia deve ser efectuada por Ressonância 
Magnética (RM). Em primeiro lugar, é 
fundamental a determinação da sua localização 
exacta, dado que os diagnósticos diferenciais 
e abordagem terapêutica são completamente 
distintos consoante o órgão de origem. Alguns 
sinais que podem auxiliar na determinação de 
origem ovárica são: presença de folículos e de 
parênquima ovárico normal em redor da lesão 
sem plano de clivagem (“embedded organ 
sign”); deformação do contorno do ovário 
pela lesão (“beak sign”); visualização de um 
pedículo vascular ou das veias gonádicas em 
continuidade com a lesão (“sinal do ligamento 
suspensor do ovário”); desvio dos vasos ilíacos 
lateralmente e dos ureteres pélvicos posterior 
ou póstero-lateralmente.
A maioria das lesões do ovário têm componente 
quístico com elevado sinal em T2, sendo menos 
frequente a identificação de lesões hipointensas 
em T2. Existe uma ampla lista de diagnósticos 
diferenciais para lesões com hipossinal em T2, 
que inclui: lesões hemorrágicas (nomeadamente 
endometrioma), com componente de músculo 
liso (leiomioma), com tecido fibroso (fibroma, 
tecoma e cistadenofibroma) e tumores com 
celularidade mista (tumor de Brenner, “struma 
ovarii” e tumor de Krukenberg). De acordo 
com as recomendações da ESUR publicadas 
em 2017, é fundamental a sua avaliação em 
sequência de difusão com valor de b elevado. 
Quando nas sequências de b elevado estas lesões 
apresentam sinal baixo, tratam-se de lesões 
benignas, não sendo necessária investigação 
adicional. Por outro lado, quando demonstram 
sinal elevado ou intermédio é essencial a 
administração de contraste endovenoso, 
idealmente com estudo dinâmico. 
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Abstract
The evaluation of  sonographically 
indeterminate adnexal lesions should be 
performed with MRI (Magnetic Resonance 
Imaging). It is fundamental to determine 
the exact location of  the lesion, since the 
differential diagnosis and therapeutic approach 
are distinct according to the organ of  origin. 
Some signs that may indicate an ovarian origin 
are: the presence of  ovarian follicles and normal 
ovarian parenchyma surrounding the lesion, 
without a cleavage plane (“embedded organ 
sign”); a change in the ovarian contour by the 
mass (“beak sign”); visualisation of  a vascular 
pedicle or the gonadic veins leading to the 
lesion (“suspensory ligament sign”); deviation 
of  the iliac vessels laterally and of  the pelvic 
ureters posteriorly or postero-laterally.
The majority of  ovarian lesions show cystic 
components with high signal-intensity on T2 
weighted-imaging. Hypointense lesions on T2 
are less frequent. The differential diagnosis for 
T2 hypointense ovarian lesions can be vast: 
haemorrhagic lesions (namely endometrioma); 
presence of  smooth muscle (leiomyoma); 
presence of  fibrous tissue (fibroma, thecoma 
and cystadenofibroma) and tumours with 
mixed cellularity (Brenner tumour, “struma 
ovarii” and Krukenberg tumour). 
According to the ESUR recommendations 
published in 2017, diffusion-weighted imaging 
(DWI) should be applied for those lesions, 
using high b-values. The lesions that show low-
signal intensity on DWI are classified as benign 
and do not require further investigation. On 
the other hand, for lesions that demonstrate 
intermediate or high signal on DWI, it is 
essential to administrate intravascular contrast, 
ideally with dynamic-contrast enhanced 
imaging (DCE).
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Introduction
The identification of  ovarian tumours is frequent in clinical 
practice, either incidentally or in symptomatic patients,1 
and these constitute the main indication for gynaecological 
surgery.2 There is a wide spectrum of  differential diagnoses 
for adnexial pelvic tumours, including benign and malignant 
tumours and non tumoral pathology.3 Thus, a preoperative 
radiological characterisation is essential for therapeutic 
decision purposes and the definition of  a surgical protocol 
as, for example, in the case of  benign ovary tumours, 
laparoscopy has been replacing open surgery.4
Ultrasound is the first line technique in the study of  
adnexal tumours.2 However, this technique may be limited 
in particular by poor acoustic window and depth of  
penetration.3 When an adnexal lesion is sonographically 
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indeterminate, magnetic resonance imaging (MRI) should 
be performed.5,6 MRI multiplanar characteristics and 
high tissue contrast allow more detailed morphological 
information to be obtained, namely the location, 
dimensions and cystic/solid composition of  the lesion.7 In 
fact, MRI has high specificity, namely in the diagnosis of  
benign pathology.8
In the characterisation of  adnexal lesions, some questions 
must be answered by the radiologist: definition of  the exact 
origin of  the lesion (ovarian/extra-ovarian); for ovarian 
lesions, determination of  its physiological or pathological 
nature (namely neoplastic); if  it is a neoplastic lesion with 
surgical indication, definition of  the risk of  malignancy and 
potential differential diagnoses.4,9
The T2-weighted sequences are included in the usual MRI 
protocol for the characterisation of  adnexal lesions. Most 
of  the identified ovarian lesions have a cystic component 
with a high T2 signal, and the identification of  T27 
hypointense lesions is less frequent.
The present article is intended to indicate the differential 
diagnoses of  the T2 hypointense lesions of  the ovary and 
their characteristics in MRI. In addition, the diagnostic 
algorithm established by the most recent ESUR 
recommendations (2017) is presented.10
1. Determination of  lesion location (ovarian 
vs. uterine origin)
When a pelvic tumour is identified, the first step is to 
determine its compartment or organ of  origin, since 
the differential diagnoses and therapeutic approach are 
completely different depending on the location.3,4,7 Some 
aspects that may help in this evaluation include: visualisation 
of  ovarian structures, type of  contour deformity at the 
interface between ovary and pelvic tumour, deviation of  
vessels, ureters and other pelvic organs.4
When both ovaries are visualised separately from the 
lesion, it will necessarily have an extra-ovarian origin.7 
However, when it is a large tumour, it may not be possible 
to visualise the ovary.4 The observation of  follicles can 
help to identify the ovaries, especially when dealing with 
small lesions.4,7 Thus, the presence of  follicles and normal 
ovarian parenchyma adjacent to the lesion, without a 
cleavage plane (embedded organ sign), and the non-
identification of  the homolateral ovary, point to ovarian 
origin (Fig. 1).3,4 Similarly, when the mass deforms the 
edge of  the ovary into a beak shape (beak sign), it points 
to ovarian origin.4 Another sign that may indicate ovarian 
origin is the visualisation of  a vascular pedicle or gonadal 
veins in continuity with the lesion.3,7,11 This sign is termed 
“ovary suspensory ligament sign”.11 Typically, an adnexal 
lesion laterally displaces the iliac vessels, while extra-ovarian 
tumours originating from the pelvic wall/adenomegalies 
tend to medially dislocate the iliac vessels.4 Since the 
ovaries are located anterior or anteromedial to the ureters, 
an ovarian mass may displace the ureters posteriorly or 
posterolaterally, whereas a tumour in the extraperitoneal 
space usually displaces the ureter anteriorly and medially.3,11
The identification of  a pedicle between the uterus and the 
lesion indicates its uterine origin.7 The most frequent T2 
hypointense uterine lesions are leiomyomas. In the majority 
of  leiomyomas, the claw sign can also be observed, which 
consists of  the presence of  a myometrial band around 
the lesion.4 The bridging vessel sign is characterised by 
the presence of  tortuous vascular structures between the 
tumour and the uterus, also indicating uterine origin11 (Fig 
2). This aspect can be visualised by ultrasound, in which it 
is also possible to identify movement of  the tumour with 
the mobilisation of  the uterus. On MRI, the bridging vessel 
sign is better identified on T1-weighted sequences after 
gadolinium and also on T2-weighted imaging, where the 
vascular “signal voids”7 can be seen.
When a para-uterine lesion with no uterine or ovarian 
origin is identified, the hypothesis of  fallopian tube 
pathology should be considered. Tubal tumours can usually 
be individualised from the uterus and ovary, although they 
may be attached to the ovary by adhesions.7 The presence 
of  incomplete septa in the wall of  a cystic adnexal tumour 
points to its tubal origin4,9 (Fig. 3). The most frequent 
Figure 1 – Brenner tumour. Pelvic MRI of  a 39-year-old woman, where 
it is possible to observe a T2 hypointense lesion, surrounded by normal 
ovarian parenchyma. The tumour deforms the edge of  the ovary into a 
beak shape (beak sign) A small ovarian follicle can be identified at the 
periphery (arrow). These findings favour its origin in the right ovary.
Figure 2 – Subserosal uterine leiomyoma. Pelvic MRI of  a 64-year-old woman. (a) Axial T2-weighted image, where it is possible to detect a signal 
void corresponding to of  vascular structures between the lesion and the uterus (bridging vessel sign) - arrow. These vascular structures are best 
visualised on coronal T1-weighted images with fat saturation after intravenous contrast (b) and (c) - arrows.
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On MRI, endometriomas are usually multiple and show 
high signal intensity on T1WI (given the presence of  
methemoglobin).7,9,12-14,16 This high signal is frequently 
easier to detect on T1WI with fat saturation, especially 
when of  reduced dimensions.7,13 On  T2WI, they usually 
exhibit homogeneous shading, which is characterised by 
the loss of  signal on T2 from a ovarian cyst with high signal 
intensity on T1WI4,7,12,16 (Fig. 4). This low signal on T2WI 
images results from the presence of  iron, high protein 
concentration and increased viscosity over time, which is 
caused by repeated haemorrhage and degradation of  non- 
recent blood components.7,12,13
However, not all endometriomas present this degree 
of  T2 shortening, depending on their age, hemosiderin 
concentration and proteins. Dependent layering and a 
hypointense fluid level that represents the presence of  
blood components with different ages can be seen.7 A T2 
hypointense peripheral ring (by deposition of  hemosiderin 
on the wall of  chronic lesions)7,13 may also be seen. Another 
sign that can be visualised in endometriomas is the T2 dark 
spot sign, which is characterised by the presence of  small 
spots markedly hypointense on T2 inside the lesion, which 
constitutes a very specific sign of  endometriomas(Fig 5).12
The shading on T2WI is not exclusive of  endometriomas,4 
and may occur in other haemorrhagic lesions such as 
haemorrhagic cysts, although they are usually hyperintense 
on T2WI7,12 (Fig. 6). Recent studies indicate that  diffusion 
weighted-imaging (DWI) may play a role in distinguishing 
between endometriomas and haemorrhagic cysts with 
this behaviour, particularly through ADC values (lower in 
haemorrhagic cysts).16
Malignant transformation of  endometriomas is rare and 
is estimated to occur in about 1% of  patients. The most 
common histological subtypes are endometrioid carcinoma 
and clear cell carcinoma. The radiological aspects that 
should raise suspicion of  malignant transformation are the 
increase in size and loss of  T2 shading. The presence of  
contrast-enhancing mural nodules is the most important 
signal.7
• A.2 Ovarian torsion with haemorrhagic infarction
Torsion of  the ovary is a common gynaecological 
emergency.11 The radiological aspect of  ovarian torsion 
depends on the severity and chronicity of  the vascular 
compromise. When the torsion of  the ovary remains 
untreated, it may progress to haemorrhagic infarction.15 
Figure 3 – Haematosalpinx. Pelvic MRI of  49-year-old woman. (a) Axial T2-weighted image; (b) Axial T1-weighted image. It is possible to visualise a 
complex tumour in the left adnexal region (circle) with incomplete septa in its wall (arrows), which point to its tubal origin. On the T1-weighted image, 
it shows spontaneous high signal intensity, which corresponds to blood content (haematosalpinx).
T2 hypointense lesions of  the fallopian tube include 
haematosalpinx, tubal leiomyoma, fibroma, and abscess.7
2. T2 Hypointense ovarian lesions 
There are different morphological and histological entities 
that can result in T2 shortening and, therefore, present with 
low signal in this sequence. These include haemorrhagic 
lesions, smooth muscle, fibrous tissue, calcifications, air, 
“signal void” artifact and paramagnetic substances such as 
melanin.7
A. Haemorrhagic lesions
Signal characteristics of  a haemorrhagic lesion on MRI 
depend on the age of  the hemorrhage and whether 
the blood components are intra- or extracellular.7 
Acute haemorrhage behaves according to intracellular 
deoxyhemoglobin: low signal intensity on T1-weighted 
images and it shows markedly low signal intensity on 
T2-weighted images (WI). In subacute haemorrhage (3-5 
days), there is intracellular methemoglobin and therefore 
high signal intensity on T1WI, which results from its 
paramagnetic effects. T2 signal is variable and depends 
on methemoglobin location. When intracellular, there is 
T2 shortening and so low signal intensity on T2WI.14 By 
contrast, extracellular methaemoglobin (late subacute 
haemorrhage) shows high signal intensity on T2WI.7 In 
the chronic phase, haemorrhage can show low signal on 
T1WI and T2WI, given the presence of  intracellular forms 
of  ferritin and hemosiderin, which produce a magnetic 
susceptibility effect.14,15 The deposition of  hemosiderin on 
the wall of  a mature hematoma may also present low signal 
on T2WI as a result of  magnetic susceptibility effects.7,15 
These effects also result in significant signal intensity loss 
on T2*.15
• A.1 Endometrioma
Endometriosis is defined as the presence of  stroma 
and endometrial glands outside the uterine cavity8,12-14 
and usually occurs in women of  childbearing age.14 Its 
prevalence is around 15%.9 The most common locations 
include the ovaries, uterine ligaments, fallopian tubes, 
recto-vaginal septum, Douglas pouch, and bladder 
wall.13 About 80% of  endometriosis cases present ovary 
involvement.14 Endometrioma occurs when implants of  
ectopic endometrial tissue increase in volume and undergo 
repeated haemorrhage, forming cystic lesions, which are 
more common in the ovary.12
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Figure 5 – Bilateral endometriomas. 
Pelvic MRI of  a 45-year-old woman. 
(a) Axial T1WI, where bilateral adnexal 
lesions with spontaneous high T1 
signal are shown. On T2WI (b), the 
right adnexial lesion (circle) shows 
heterogeneous loss of  signal, with fluid-
fluid level (arrow). Left adnexal lesion 
(dashed circle) presents T2 hypersignal, 
with focus of  T2 hypointensity (T2 
dark spot sign) – dashed-line arrow. 
(c) and (d) correspond to DWI (b-
1000) and ADC map, respectively, 
where there is a restricted diffusion, 
more evident in the right ovarian 
endometrioma. (e) and (f) T1-weighted 
images with fat saturation before and 
after intravenous contrast, respectively, 
in which the endometriomas maintain 
an identical appearance, since they 
present spontaneous T1 high signal, 
without enhancement after intravenous 
contrast. 
Figure 6 – Haemorrhagic cyst. Pelvic 
MRI of  a 33-year-old woman. (a) 
Coronal T1-weighted image, where 
it is shown a left adnexal lesion with 
spontaneous hypersignal (circle). (b) 
Coronal T2-weighted image where 
this lesion also shows hypersignal. 
This is the most typical behaviour of  
haemorrhagic cysts on MRI.
Figure 4 – Endometrioma. Pelvic 
MRI of  42-year-old woman. (a) 
Axial T1-weighted image where it is 
possible to see an adnexal tumour 
with spontaneous high signal intensity 
(circle), which loses signal in a relatively 
homogeneous way on the T2-weighted 
image (b) - shading; (c) and (d) 
represent DWI (b-1000) and ADC 
map, respectively, where it is possible 
to appreciate that this lesion presents 
restricted diffusion.
13
On MRI, findings of  ovarian torsion are nonspecific and 
are characterised by increased ovarian volume, peripheral 
distribution of  the follicles, deviation of  the uterus to the 
affected ovary, engorgement of  the homolateral vessels, 
thickening of  the fallopian tube and ascites.11,15 When the 
torsion progresses to haemorrhagic infarction, in addition 
to these signs, low T2 signal intensity is observed due 
to the presence of  interstitial haemorrhage. A thin T1 
hyperintense halo may also be visualised, which does not 
enhance after intravenous contrast. It is easily distinguished 
from endometriomas, namely since they do not usually 
involve the entire ovary.15
B. Smooth muscle 
The smooth muscle shows low signal on T2WI, due to the 
T2-shortening effect caused by actin, myosin and collagen, 
as well as by the lower extracellular fluid component in 
relation to the adjacent tissues.7
Leiomyomas are benign tumours that originate in any 
structure or organ containing smooth muscle.14 Uterine 
leiomyomas constitute the most frequent gynaecological 
tumour, occurring in about 20-30% of  women of  
childbearing age.17 In the absence of  degeneration, they 
present low to intermediate signal on T1WI and low signal 
on T2WI9 and are usually well circumscribed.14 Exophytic 
uterine leiomyomas may mimic T2 hypointense adnexal 
tumours, thus constituting an important differential 
diagnosis.7 To distinguish them, it is important to note the 
characteristics described above in section 1. Determination 
of  lesion location (ovarian vs. uterine origin). 
Primary leiomyoma of  the ovary is a very rare entity, with 
fewer than 80 cases reported in the medical literature. It 
presents radiological characteristics identical to the smooth 
muscle in other locations (Fig. 7). Other extrauterine 
leiomyomas may originate in the fallopian tubes and round 
ligament.7
C. Fibrous tissue
Fibrous tissue is characterised by low cellular or acellular 
material with a high proportion of  collagen and few 
cells and vessels. Like compact smooth muscle, this type 
of  tissue demonstrates intermediate signal on T1WI and 
very low signal on T2WI.7,15 Different amounts of  fibrous 
tissue can be found within the tumours, but in the ovarian 
tumours described below fibrosis is a dominant component 
(fibroma, thecoma and cystadenofibroma).15
• C.1 Fibroma and Thecoma
These are the most common benign solid tumours of  
the ovary6 and correspond to most ovarian sex cord-
stromal tumours4. They occur in both pre-menopausal and 
postmenopausal women18 and are typically asymptomatic 
and incidentally detected.13 Most of  them are unilateral 
(90%).4
Fibromas are composed mostly of  fibroblasts and spindle 
cells and abundant collagen4,19 and they are not hormone 
producers.4 They may be associated with ascites and pleural 
Figure 7 – Primary leiomyoma of  the 
left ovary. Pelvic MRI of  52-year-
old woman. (a) Axial T2-weighted 
image: the left ovarian lesion (circle) is 
markedly hypointense on T2WI (signal 
similar to muscle tissue). (b) Sagittal 
T2-weighted image where it is possible 
to appreciate the same characteristics. 
(c) and (d) correspond to DWI (b-1000) 
and ADC map, respectively, where 
it is shown that this lesion does not 
present restricted diffusion. (e) T1WI 
with fat saturation after intravenous 
contrast-enhancement - T1 SPAIR 
(dynamic study) and (f) delayed phase 
after intravenous contrast - T1 SPIR, 
where it is possible to appreciate 
the enhancement of  the lesion, 
which is not superior to that of  the 
myometrium.
effusion, constituting the Meigs Syndrome.7 This triad may 
also be associated with elevation of  CA-125 values.4
Thecomas are composed of  thecal cells with abundant and 
variable amounts of  fibrosis, and may contain amorphous 
calcifications.4 As opposed to fibromas, they present 
estrogenic endocrine activity that can result in endometrial 
hyperplasia and formation of  polyps,7 which can cause 
uterine haemorrhage. In addition, in more than 20% of  
the cases, endometrial carcinoma occurs, concomitantly.4 
Thus, an endometrial thickening associated with an ovary 
tumour with low T2WI signal should raise the suspicion of  
a functioning thecoma.15
Its main MRI characteristics are: non-specific hypo or 
isointensity on T1WI and low signal on T2WI, which is 
characteristic of  these tumours.7 They thus present features 
similar to uterine leiomyomas without degeneration,4 
which constitute its main differential diagnosis6. Areas of  
high T2 signal within the solid low signal intensity lesion, 
attributable to oedema or cystic degeneration, are frequent 
in larger tumours(Fig. 8).4,7,13,15
A small amount of  ascites is also common, which is not a 
sign of  malignancy.4 Both the fibromas and the thecomas 
usually present mild and delayed enhancement after 
intravenous contrast (type 1 curve),4,7,10 lower than that of  
myometrium and leiomyomas(Fig. 9 and 10).19
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Rarely, cellular fibromas may be found, corresponding to 
about 10% of  fibrous tumours of  the ovary (Fig. 11).20 
These are well vascularised and have a low potential for 
malignancy.21 
• C.2 Cystadenofibroma
Cystadenofibroma corresponds to an unusual benign ovary 
tumour consisting of  fibrous stroma and an epithelial cystic 
component.7,22 The presence of  rims, septa or nodules with 
low signal intensity on T2WI within a multiloculated cystic 
ovarian tumour suggests the diagnosis.15 The radiological 
aspect of  cystadenofibromas depends on the predominant 
component (cystic or fibrous).7 The T2 hypointense 
portions may range from 2 mm to 4 cm and correspond to 
the regions of  fibrous intra-tumoral tissue.15 These regions 
usually present mild enhancement on the post-contrast 
study(Fig. 12).7 Cystadenofibromas may also behave on 
MRI as purely cystic lesions, practically indistinguishable 
from cystadenomas, although this appearance is less 
frequent.1
Although most cystadenofibromas are benign, they have 
malignant potential and therefore surgical indication. 
Despite this, it is of  the utmost importance to establish a 
pre-surgical MRI diagnosis, since it can avoid performing 
more extensive surgeries, which are only necessary in the 
approach of  malignant tumours.7
Figure 8 – Right ovarian fibroma. 
Pelvic MRI of  a 77-year-old woman. 
(a) Axial T2-weighted image, which 
shows a large lesion (circle) with a 
hypointense solid component and also 
with a high T2 signal component (*), 
corresponding to cystic degeneration, 
common in lesions with a large 
dimension. (b) Sagittal T2WI. (c) 
and (d) DWI (b-1000) and ADC 
map, respectively. There is restricted 
diffusion of  the solid component. 
(e) Axial T1-weighted image with 
fat saturation after intravenous 
contrast- T1 SPAIR (dynamic study) 
and (f) delayed acquisition (T1 SPIR), 
where it is possible to detect mild 
enhancement of  the solid component.
15
Figure 9 – Thecoma of  the right ovary. Pelvic MRI of  
a 69-year-old woman. (a) and (b) correspond to axial 
and sagittal T2-weighted images, respectively, where a 
right ovarian lesion is shown, with an intermediate T2 
signal (circle). (c) and (d) DWI (b-1000) and ADC map, 
respectively, showing restricted diffusion. On the post-
contrast images-axial T1 SPAIR (e) and (f) there is a mild 
and delayed enhancement of  this lesion, inferior to that 
of  the myometrium (arrow). Although the T2 signal is 
intermediate, which does not correspond to the more 
typical aspect, the behaviour of  the lesion in the dynamic 
study favours its fibrous nature. The anatomopathological 
study revealed a thecoma.
Figure 10 – Right ovarian thecoma. Pelvic MRI of  
a 60-year-old woman. (a) and (b) Axial and sagittal 
T2-weighted images, respectively, where a large 
heterogeneous right ovarian tumor (circle) is shown, 
with an intermediate T2 signal and central areas of  
marked low T2 signal. (c) axial T1 and (d) axial T1 
with fat saturation after intravenous contrast -axial T1 
SPAIR, where a mild enhancement is observed, inferior 
to that of  the myometrium (arrow). (e) and (f) DWI 
(b-1000) and ADC map, respectively, showing restricted 
diffusion,, especially of  the more peripheral region. The 
anatomopathological study revealed a thecoma.
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Figure 11 – Cellular fibroma of  the left ovary. Pelvic 
MRI of  a 60-year-old woman. (a) and (b) Axial and 
sagittal T2-weighted images, respectively, where it is 
possible to observe a heterogeneous tumour (circle), 
of  mixed nature, with multicystic component and solid 
regions of  intermediate T2 signal. (c) and (d) DWI 
(b-1000) and ADC map, respectively, showing restricted 
diffusion of  the solid component. In the study after 
intravenous contrast - axial T1 SPAIR (e) and in the 
delayed axial acquisition SPIR (f) there is heterogeneous 
enhancement of  the solid component. The 
anatomopathological study revealed a cellular fibroma.
Figure 12 – Cystadenofibroma of  the right ovary. 
Pelvic MRI of  a 75-year-old woman. (a) and (b) Axial 
and sagittal T2-weighted images, respectively, showing a 
large cystic tumour (circle), which shows T2 hypointense 
septae (arrows). (c) and (d) DWI (b-1000) and ADC map, 
respectively, showing no restricted diffusion.
In the study after intravenous contrast - axial T1 SPAIR 
(e) and in the delayed axial acquisition SPIR (f), there is 
mild enchancement of  the septae (dashed arrows).
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D. Mixed Cellularity 
• D.1 Brenner Tumour 
Brenner tumour is a rare ovarian epithelial-stromal 
tumour,7 usually benign,1 corresponding to about 2% of  
ovarian tumours. Typically it consists of  a fibrous stromal 
component associated with calcifications and transitional 
cells, which are histologically similar to the urothelial 
epithelium.7,14 Most of  them occur between 30 and 59 
years of  age.23 They may be associated with other ovarian 
tumours, in particular cystadenomas, in about 30% of  
cases.6,14,18 Although rare, there are borderline and malignant 
forms (transitional cell carcinoma),1 corresponding to less 
than 2% of  the cases. They are rarely oestrogen producers.4
The most common radiological features of  Brenner 
tumours are: solid and small lesions (about 60% below 
2 cm), most commonly unilateral.4 They usually present 
low signal intensity on T2WI, due to its solid components 
(fibrous stroma).6,14 The presence of  amorphous 
calcifications in small tumours is typical of  this entity, but 
sometimes difficult to detect by MRI.4,6,18 Although the 
radiological features of  the Brenner tumour overlap those 
of  fibromas and thecomas, they typically exhibit at least 
moderate enhancement after intravenous contrast, whereas 
fibromas and thecomas are usually hypovascular(Fig. 13).7,14
The borderline Brenner tumour is characteristically 
manifested as a cystic tumour with solid elements and 
papillary projections. On the other hand, malignant Brenner 
tumour is typically a multilocular cystic tumour with large 
solid components.7
• D.2 Struma ovarii
The designation struma ovarii refers to mature cystic 
teratomas consisting entirely or predominantly of  thyroid 
tissue and containing follicles of  varying dimensions with 
colloid material,14 which is associated with haemorrhage, 
fibrosis and necrosis.4 Rarely they can manifest with 
thyrotoxicosis.1,4 They constitute a rare type of  ovarian 
tumour (0.30-0.65% of  ovarian tumours and 2% of  ovarian 
teratomas). They are benign in about 95% of  cases and 
occur mainly in premenopausal women.7
Some cystic spaces usually show low signal on both 
T1 and T2WI, due to its thick and gelatinous colloid 
component.1,6,7,14 Other cystic spaces show high T1 signal 
due to hemorrhage.7 Fat components are not present in 
this type of  tumour.1,4 They usually demonstrate strong 
enhancement of  the solid components on T1WI after 
intravenous contrast(Fig. 14).7
• D.3 Krukenberg Tumour
Krukenberg tumours are matastatic ovarian tumours 
that contain mucin-secreting signet-ring cells.1,18 They 
thus correspond to adenocarcinomas, which originate 
most frequently from the stomach (70%), breast, colon 
and appendix. They constitute about 1-2% of  all ovarian 
tumours and are bilateral in 60-80% of  patients.7
Ovarian metastases may have cystic and solid or 
predominantly solid characteristics1 and may mimic 
primary tumours.18 Krukenberg tumours in particular 
usually present as solid tumours with poorly defined intra-
tumoural cysts (haemorrhage or cystic necrosis). They 
show variable hypointensity on T2WI due to the presence 
of  cells filled with mucin, ovarian stroma and abundant 
Figure 13 – Brenner tumour of  the left 
ovary. Pelvic MRI of  58-year-old woman. (a) 
Axial T2-weighted image, where a a small 
solid tumour of  the left ovary is shown, 
with marked T2 low signal. (b) T1-weighted 
image, where the tumour is isointense with 
the muscle. (c) and (d) DWI (b-1000) and 
ADC map, respectively, where it can be seen 
that there is no restricted diffusion. On the 
axial T1-weighted image after intravenous 
contrast T1 SPAIR (e) and on the delayed 
axial acquisition SPIR (f) there is moderate 
enhancement, which is more expressive 
than the usual for fibromas and thecomas 
(suggestion: comparison with Fig. 9e) .
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collagen formation.7 In fact, the presence of  hypointense 
solid components on T2WI, peripheral or with random 
distribution (corresponding to the stromal collagen), 
although not specific, should suggest the diagnosis, 
especially when bilateral14,18,25 (Fig. 15). After intravenous 
contrast, they show moderate to strong enhancement of  the 
solid component and pericystic rim, which is uncommon 
for other solid ovarian lesions.7
Figure 14 – Struma ovarii of  
the right ovary. Pelvic MRI of  
a 46-year-old woman. (a) Axial 
T2-weighted image where there 
is a large lesion with mixed 
characteristics (circle), with 
heterogeneous solid and cystic 
components. (b) Axial T1-weighted 
image, where a spontaneously 
hyperintense area(*) is identified, 
which shows no loss of  signal on 
the T1-weighted image with fat 
saturation (c), thus corresponding 
to haemorrhage. On the T1-
weighted image after intravenous 
contrast T1 SPAIR (d) the solid 
component shows enhancement.
MRI evaluation protocol (ESUR recommendations 
2017)
In 2017, an update of  the recommendations of  ESUR10 
was published for evaluation of  indeterminate adnexal 
tumours by ultrasound. According to these guidelines the 
baseline protocol for evaluation of  T2 hypointense lesions 
of  the ovary should include: a sagittal T2WI of  the pelvis, 
Figure 15 – Krukenberg tumour of  the right 
ovary. Pelvic MRI of  a 30-year-old woman 
with a history of  mucinous adenocarcinoma 
of  the colon. (a) and (b) correspond to axial 
and sagittal T2 sequences, respectively, where 
it is possible to observe a large heterogeneous 
tumour (circle), of  mixed nature, with 
multicystic component and solid regions of  
predominantly T2 intermediate signal. The 
presence of  peripheral solid components 
with significant low signal on T2WI(arrows) 
is highlighted. (c) and (d) DWI (b-1000) and 
ADC map, respectively, showing restricted 
diffusion of  the solid component. (e) T1 
weighted-image; (f) T1 weighted-image with 
fat saturation after intravenous contrast (T1 
SPAIR), where there is moderate to strong 
enhancement of  the solid component.
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Figure 16 – Flowchart. Summary of  ESUR recommendations (2017) for 
evaluation of  T2 hypointense adnexal lesions
a pair of  axial T1WI and T2WI through the indeterminate 
mass and eventually a T2WI in the long axis of  the uterus. 
To determine the origin of  the tumour (ovarian or uterine) 
in doubtful cases, an oblique sequence through the point of  
maximum contact between the tumour and the uterus can 
be useful, namely to identify bridging vessels and confirm 
the origin of  the lesion.
Solid tumours of  the ovary with a low T2 signal should also 
always be evaluated by DWI. When these demonstrate low 
signal on DWI with high b values (greater than 800 s/mm2), 
they can be considered benign and intravenous contrast 
administration is not necessary. On the other hand, when 
this is not its behaviour on DWI, intravenous contrast 
should be administered, ideally conducting a dynamic 
study. These recommendations are summarised in Fig.16.
In the evaluation of  DWI, it is important to ensure that 
the used b-value is adequate. According to the rules of  
ESUR 201710, the urine signal inside the bladder must be 
observed. When urine still shows a high signal, the b-value 
should be increased. The b-value from which urine has very 
low signal intensity is adequate and then evaluation of  the 
ovarian tumour can be performed.
Conclusion
The first step in evaluating a tumour with possible adnexal 
origin is to determine its exact location. There is a broad 
spectrum of  T2 hypointense lesions of  the ovary, including 
haemorrhagic lesions (namely endometrioma), with 
smooth muscle component (leiomyoma), fibrous tissue 
(fibroma, thecoma and cystadenofibroma) and tumours 
with mixed cellularity (Brenner tumour, Struma ovarii and 
Krukenberg’s tumour).
For the diagnosis of  these lesions, the approach 
recommended by  ESUR (2017) consists of  its evaluation 
on DWI with high b-values. When they show low signal 
on this sequence, these are benign lesions and no further 
investigation is necessary. However, if  they exhibit high or 
intermediate signal on DWI, it is mandatory to carry out 
post- intravenous contrast evaluation, ideally with dynamic 
study. Fibrous tumours, such as fibroma and thecoma, 
usually show a mild and delayed enhancement after 
intravenous contrast, inferior to that of  the myometrium 
and leiomyomas.
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